AP-23588

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameAP-23588
Drug Alias NameAP23588
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSRC inhibitors
TargetsSRC
Therapy Area/IndicationsOsteitis DeformansOsteoporosis, Postmenopausal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAriad Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAriad Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsOsteitis DeformansOsteoporosis, Postmenopausal

Other Information

ATC CodeN/A
Related LinksN/A